Current and historical daily PE Ratio for STA (
Starton Therapeutics Inc
) from 2050 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Starton Therapeutics stock (STA) PE ratio as of Jun 08 2024 is 0.
More Details
Starton Therapeutics Inc (STA) PE Ratio (TTM) Chart
Starton Therapeutics Inc (STA) PE Ratio (TTM) Historical Data
View and export this data going back to 2050. Start your Free Trial
Total 0
- 1
| Starton Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Starton Therapeutics Inc (STA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Starton Therapeutics Inc
NAICS : 541713
SIC : 3741
Description
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers